Huntington's disease: The value of transcranial meganetic stimulation

Current Medicinal Chemistry

Volumn 17, Issue 23, 2010, Pages 2482-2491

  Medina, F J ^a   Tunez I ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

Huntington's disease; neuroplasticity; oxidative stress; transcranial

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HUNTINGTIN; METABOTROPIC RECEPTOR; MUTANT PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURITE PROMOTING FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; POLYGLUTAMINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME 4; EPILEPSY; GENETIC TRANSCRIPTION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; MAJOR DEPRESSION; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA; STROKE; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; HUMANS; HUNTINGTON DISEASE; MAGNETIC FIELD THERAPY; NEURONAL PLASTICITY; OXIDATIVE STRESS;

EID: 77955638751     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791556078     Document Type: Article

References (126)

1. Martin, J. B.; Gusella, J. F. Huntington's disease. Pathogenesis and management. N. Engl. J. Med., 1986, 315(20), 1267-76.
2. Rubinsztein, D. C. Genetics of movement disorders. S Pulst, Academic Press California: California, 2003.
3. Harper, P. S. J. L. Huntington's disease. Oxford University Press: New York, 2002.
4. Mahant, N.; McCusker, E. A.; Byth, K.; Graham, S. Huntington's disease: clinical correlates of disability and progression. Neurology, 2003, 61(8), 1085-92.
5. Squitieri, F.; Cannella, M.; Simonelli, M. CAG mutation effect on rate of progression in Huntington's disease. Neurol. Sci., 2002, 23 Suppl 2, S107-8.
6. Foroud, T.; Gray, J.; Ivashina, J.; Conneally, P. M. Differences in duration of Huntington's disease based on age at onset. J. Neurol. Neurosurg. Psychiatry, 1999, 66(1), 52-6.
7. Kremer, B.; Almqvist, E.; Theilmann, J.; Spence, N.; Telenius, H.; Goldberg, Y. P.; Hayden, M. R. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am. J. Hum. Genet., 1995, 57(2), 343-50.
8. Ranen, N. G.; Stine, O. C.; Abbott, M. H.; Sherr, M.; Codori, A. M.; Franz, M. L.; Chao, N. I.; Chung, A. S.; Pleasant, N.; Callahan, C.; et al. Anticipation and instability of IT-15(CAG)n repeats in parent-offspring pairs with Huntington disease. Am. J. Hum. Genet., 1995, 57(3), 593-602.
9. Trottier, Y.; Biancalana, V.; Mandel, J. L. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J. Med. Genet., 1994, 31(5), 377-82.
10. Landles, C.; Bates, G. P. Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep., 2004, 5(10), 958-63.
11. Chiang, M. C.; Chen, H. M.; Lee, Y. H.; Chang, H. H.; Wu, Y. C.; Soong, B. W.; Chen, C. M.; Wu, Y. R.; Liu, C. S.; Niu, D. M.; Wu, J. Y.; Chen, Y. T.; Chern, Y. Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum. Mol. Genet., 2007, 16(5), 483-98.
12. Jiang, H.; Poirier, M. A.; Liang, Y.; Pei, Z.; Weiskittel, C. E.; Smith, W. W.; DeFranco, D. B.; Ross, C. A. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol. Dis., 2006, 23(3), 543-51.
13. Illuzzi, J.; Yerkes, S.; Parekh-Olmedo, H.; Kmiec, E. B. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates. J. Neurosci. Res., 2009, 87(3), 733-47.
14. Bae, B. I.; Xu, H.; Igarashi, S.; Fujimuro, M.; Agrawal, N.; Taya, Y.; Hayward, S. D.; Moran, T. H.; Montell, C.; Ross, C. A.; Snyder, S. H.; Sawa, A. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron, 2005, 47(1), 29-41.
15. Dunah, A. W.; Jeong, H.; Griffin, A.; Kim, Y. M.; Standaert, D. G.; Hersch, S. M.; Mouradian, M. M.; Young, A. B.; Tanese, N.; Krainc, D. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 2002, 296(5576), 2238-43.
16. Qiu, Z.; Norflus, F.; Singh, B.; Swindell, M. K.; Buzescu, R.; Bejarano, M.; Chopra, R.; Zucker, B.; Benn, C. L.; DiRocco, D. P.; Cha, J. H.; Ferrante, R. J.; Hersch, S. M. Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J. Biol. Chem., 2006, 281(24), 16672-80.
17. Browne, S. E.; Beal, M. F. Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. Biochem. Soc. Trans., 1994, 22(4), 1002-6.
18. Trushina, E.; McMurray, C. T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience, 2007, 145(4), 1233-48.
19. Tang, T. S.; Tu, H.; Orban, P. C.; Chan, E. Y.; Hayden, M. R.; Bezprozvanny, I. HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons. Eur. J. Neurosci., 2004, 20(7), 1779-87.
20. Bradford, J.; Shin, J. Y.; Roberts, M.; Wang, C. E.; Li, X. J.; Li, S. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc. Natl. Acad. Sci. U.S.A., 2009, 106(52), 22480-5.
21. Bradford, J.; Shin, J. Y.; Roberts, M.; Wang, C. E.; Sheng, G.; Li, S.; Li, X. J. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J. Biol. Chem., 2010.
22. Gong, B.; Lim, M. C.; Wanderer, J.; Wyttenbach, A.; Morton, A. J. Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death. Brain Res. Bull., 2008, 75(1), 146-57.
23. Venkatraman, P.; Wetzel, R.; Tanaka, M.; Nukina, N.; Goldberg, A. L. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutaminecontaining proteins. Mol. Cell, 2004, 14(1), 95-104.
24. Young, A. B.; Shoulson, I.; Penney, J. B.; Starosta-Rubinstein, S.; Gomez, F.; Travers, H.; Ramos-Arroyo, M. A.; Snodgrass, S. R.; Bonilla, E.; Moreno, H.; Wexler N.S. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology, 1986, 36 (2), 244-9.
25. Craufurd, D. S. J. Huntington's disease. Bates, G.; Harper, P.; Jones, L.; Eds. Oxford University Press: New York, 2002.
26. Baliko, L.; Csala, B.; Czopf, J. Suicide in Hungarian Huntington's disease patients. Neuroepidemiology, 2004, 23(5), 258-60.
27. Robins Wahlin, T. B.; Backman, L.; Lundin, A.; Haegermark, A.; Winblad, B.; Anvret, M. High suicidal ideation in persons testing for Huntington's disease. Acta Neurol. Scand., 2000, 102(3), 150-61.
28. Walker, F. O. Huntington's disease. Lancet, 2007, 369(9557), 218-28.
29. Sayre, L. M.; Perry, G.; Smith, M. A. Oxidative stress and neurotoxicity. Chem. Res. Toxicol., 2008, 21(1), 172-88.
30. Browne, S. E.; Beal, M. F. Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox. Signal., 2006, 8(11-12), 2061-73.
31. Browne, S. E.; Ferrante, R. J.; Beal, M. F. Oxidative stress in Huntington's disease. Brain Pathol., 1999, 9(1), 147-63.
32. Gutekunst, C. A.; Norflus, F.; Hersch, S. M. Recent advances in Huntington's disease. Curr. Opin. Neurol., 2000, 13(4), 445-50.
33. Yang, L.; Calingasan, N. Y.; Wille, E. J.; Cormier, K.; Smith, K.; Ferrante, R. J.; Beal, M. F. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J. Neurochem. 2009, 109(5), 1427-39.
34. Schulz, J. B.; Matthews, R. T.; Jenkins, B. G.; Ferrante, R. J.; Siwek, D.; Henshaw, D. R.; Cipolloni, P. B.; Mecocci, P.; Kowall, N. W.; Rosen, B. R.; Beal, M.F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci., 1995, 15(12), 8419-29.
35. Tabrizi, S. J.; Workman, J.; Hart, P. E.; Mangiarini, L.; Mahal, A.; Bates, G.; Cooper, J. M.; Schapira, A. H. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol., 2000, 47(1), 80-6.
36. Perez-Severiano, F.; Escalante, B.; Vergara, P.; Rios, C.; Segovia, J. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation. Brain Res., 2002, 951(1), 36-42.
37. Dexter, D. T.; Jenner, P.; Schapira, A. H.; Marsden, C. D. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol., 1992, 32 Suppl, S94-100.
38. Bartzokis, G.; Cummings, J.; Perlman, S.; Hance, D. B.; Mintz, J. Increased basal ganglia iron levels in Huntington disease. Arch. Neurol., 1999, 56(5), 569-74.
39. Grunewald, T.; Beal, M. F. Bioenergetics in Huntington's disease. Ann. N.Y. Acad. Sci., 1999, 893, 203-13.
40. del Hoyo, P.; Garcia-Redondo, A.; de Bustos, F.; Molina, J. A.; Sayed, Y.; Alonso-Navarro, H.; Caballero, L.; Arenas, J.; Jimenez-Jimenez, F. J. Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease. Neurochem. Res., 2006, 31(9), 1103-9.
41. Christofides, J.; Bridel, M.; Egerton, M.; Mackay, G. M.; Forrest, C. M.; Stoy, N.; Darlington, L. G.; Stone, T. W. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J. Neurochem., 2006, 97(4), 1078-88.
42. Tunez, I.; Drucker-Colin, R.; Jimena, I.; Medina, F. J.; Munoz Mdel, C.; Pena, J.; Montilla, P. Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease. J. Neurochem., 2006, 97(3), 619-30.
43. Tunez, I.; Montilla, P.; del Carmen Munoz, M.; Medina, F. J.; Drucker-Colin, R. Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes. Neurosci. Res., 2006, 56(1), 91-5.
44. Sorolla, M. A.; Reverter-Branchat, G.; Tamarit, J.; Ferrer, I.; Ros, J.; Cabiscol, E. Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic. Biol. Med., 2008, 45(5), 667-78.
45. Deckel, A. W. Nitric oxide and nitric oxide synthase in Huntington's disease. J. Neurosci. Res., 2001, 64(2), 99-107.
46. Norris, P. J.; Waldvogel, H. J.; Faull, R. L.; Love, D. R.; Emson, P. C. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience, 1996, 72(4), 1037-47.
47. Kumar, P.; Kumar, A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav. Brain Res., 2010, 206(1), 38-46.
48. Brusa, L.; Versace, V.; Koch, G.; Bernardi, G.; Iani, C.; Stanzione, P.; Centonze, D. Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients. Ann. Neurol., 2005, 58(4), 655-6.
49. Gage, F. H. Neurogenesis in the adult brain. J. Neurosci., 2002, 22(3), 612-3.
50. Barker, A. T.; Jalinous, R.; Freeston, I. L. Non-invasive magnetic stimulation of human motor cortex. Lancet, 1985, 1(8437), 1106-7.
51. Chen, R.; Cros, D.; Curra, A.; Di Lazzaro, V.; Lefaucheur, J. P.; Magistris, M. R.; Mills, K.; Rosler, K. M.; Triggs, W. J.; Ugawa, Y.; Ziemann, U. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin. Neurophysiol., 2008, 119(3), 504-32.
52. Auvichayapat, P.; Auvichayapat, N. Basic principle of transcranial magnetic stimulation. J. Med. Assoc. Thai., 2009, 92(11), 1560-6.
53. Moisa, M.; Pohmann, R.; Uludag, K.; Thielscher, A. Interleaved TMS/CASL: Comparison of different rTMS protocols. Neuroimage, 2010, 49(1), 612-20.
54. Rossini, P. M.; Rosinni, L.; Ferreri, F. Brain-behavior relations: transcranial magnetic stimulation: a review. IEEE Eng. Med. Biol. Mag., 2010, 29(1), 84-95.
55. Rossi, S.; Hallett, M.; Rossini, P. M.; Pascual-Leone, A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol., 2009, 120(12), 2008-39.
56. Hallett, M. Transcranial magnetic stimulation: a primer. Neuron, 2007, 55(2), 187-99.
57. Pascual-Leone, A.; Tormos, J. M.; Keenan, J.; Tarazona, F.; Canete, C.; Catala, M. D. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J. Clin. Neurophysiol., 1998, 15(4), 333-43.
58. Cheeran, B.; Koch, G.; Stagg, C. J.; Baig, F.; Teo, J. Transcranial magnetic stimulation: from neurophysiology to pharmacology, molecular biology and genomics. Neuroscientist, 2010; doi:10.1177/1073858409349901v1 (in press).
59. Cho, S. S.; Strafella, A. P. rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One, 2009, 4(8), e6725.
60. San Sebastián, J. L. M. S.; Sancho, M.; Miranda, J. M. Medición de radiaciones en seres vivos. Invest. Cienc., 2006,(353), 46-55.
61. Hoffman, R. E.; Boutros, N. N.; Berman, R. M.; Roessler, E.; Belger, A.; Krystal, J. H.; Charney, D. S. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices". Biol. Psychiatry, 1999, 46(1), 130-2.
62. Zaman, R.; Thind, D.; Kocmur, M. Transcranial magnetic stimulation in schizophrenia. Neuro Endocrinol. Lett., 2008, 29 Suppl 1, 147-60.
63. Vercammen, A.; Knegtering, H.; Liemburg, E. J.; Boer, J. A.; Aleman, A. Functional connectivity of the temporo-parietal region in schizophrenia: Effects of rTMS treatment of auditory hallucinations. J. Psychiatr. Res., 2010; doi: 10.1016/j.jpsychires. 2009.12.011 (in press).
64. Padberg, F.; George, M. S. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp. Neurol., 2009, 219(1), 2-13.
65. Klein, E.; Kreinin, I.; Chistyakov, A.; Koren, D.; Mecz, L.; Marmur, S.; Ben-Shachar, D.; Feinsod, M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch. Gen. Psychiatry, 1999, 56(4), 315-20.
66. Schutter, D. J. Quantitative review of the efficacy of slowfrequency magnetic brain stimulation in major depressive disorder. Psychol. Med., 2010, 1-7.
67. Tergau, F.; Naumann, U.; Paulus, W.; Steinhoff, B. J. Lowfrequency repetitive transcranial magnetic stimulation improves intractable epilepsy. Lancet, 1999, 353(9171), 2209.
68. Kimiskidis, V. K. Transcranial magnetic stimulation for drugresistant epilepsies: rationale and clinical experience. Eur. Neurol., 2010, 63(4), 205-210.
69. Pridmore, S.; Kleinjung, T.; Langguth, B.; Eichhammer, P. Transcranial magnetic stimulation: potential treatment for tinnitus? Psychiatry Clin. Neurosci., 2006, 60(2), 133-8.
70. Kleinjung, T.; Vielsmeier, V.; Landgrebe, M.; Hajak, G.; Langguth, B. Transcranial magnetic stimulation: a new diagnostic and therapeutic tool for tinnitus patients. Int. Tinnitus J., 2008, 14(2), 112-8.
71. Frank, G.; Kleinjung, T.; Landgrebe, M.; Vielsmeier, V.; Steffenhagen, C.; Burger, J.; Frank, E.; Vollberg, G.; Hajak, G.; Langguth, B. Left temporal low-frequency rTMS for the treatment of tinnitus: clinical predictors of treatment outcome - a retrospective study. Eur. J. Neurol., 2010; doi: 10.1111/j.1468-1331.2010.02956.x (in press).
72. Leo, R. J.; Latif, T. Repetitive transcranial magnetic stimulation (rTMS) in experimentally induced and chronic neuropathic pain: a review. J. Pain, 2007, 8(6), 453-9.
73. McComas, A.; Upton, A. Therapeutic transcranial magnetic stimulation in migraine and its implications for a neuroinflammatory hypothesis. Inflammopharmacology, 2009, 17(2), 68-75.
74. Arias-Carrion, O. Basic mechanisms of rTMS: Implications in Parkinson's disease. Int. Arch. Med., 2008, 1(1), 2.
75. Ziemann, U.; Ilic, T. V.; Jung, P. Long-term potentiation(LTP)-like plasticity and learning in human motor cortex--investigations with transcranial magnetic stimulation(TMS). Suppl. Clin. Neurophysiol., 2006, 59, 19-25.
76. Koganemaru, S.; Mima, T.; Nakatsuka, M.; Ueki, Y.; Fukuyama, H.; Domen, K. Human motor associative plasticity induced by paired bihemispheric stimulation. J. Physiol., 2009, 587(Pt 19), 4629-44.
77. Ji, R. R.; Schlaepfer, T. E.; Aizenman, C. D.; Epstein, C. M.; Qiu, D.; Huang, J. C.; Rupp, F. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc. Natl. Acad. Sci. U.S.A., 1998, 95(26), 15635-40.
78. Hausmann, A.; Weis, C.; Marksteiner, J.; Hinterhuber, H.; Humpel, C. Chronic repetitive transcranial magnetic stimulation enhances cfos in the parietal cortex and hippocampus. Brain Res. Mol. Brain Res., 2000, 76(2), 355-62.
79. Muller, M. B.; Toschi, N.; Kresse, A. E.; Post, A.; Keck, M. E. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology, 2000, 23(2), 205-15.
80. Cheeran, B.; Talelli, P.; Mori, F.; Koch, G.; Suppa, A.; Edwards, M.; Houlden, H.; Bhatia, K.; Greenwood, R.; Rothwell, J. C. A common polymorphism in the brain-derived neurotrophic factor gene(BDNF) modulates human cortical plasticity and the response to rTMS. J. Physiol., 2008, 586(Pt 23), 5717-25.
81. Ben-Shachar, D.; Belmaker, R. H.; Grisaru, N.; Klein, E. Transcranial magnetic stimulation induces alterations in brain monoamines. J. Neural. Transm., 1997, 104(2-3), 191-7.
82. Keck, M. E.; Sillaber, I.; Ebner, K.; Welt, T.; Toschi, N.; Kaehler, S. T.; Singewald, N.; Philippu, A.; Elbel, G. K.; Wotjak, C. T.; Holsboer, F.; Landgraf, R.; Engelmann, M. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur. J. Neurosci., 2000, 12(10), 3713-20.
83. Taber, M. T.; Fibiger, H. C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci., 1995, 15(5 Pt 2), 3896-904.
84. You, Z. B.; Tzschentke, T. M.; Brodin, E.; Wise, R. A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J. Neurosci., 1998, 18(16), 6492-500.
85. Meyer, B. U.; Noth, J.; Lange, H. W.; Bischoff, C.; Machetanz, J.; Weindl, A.; Roricht, S.; Benecke, R.; Conrad, B. Motor responses evoked by magnetic brain stimulation in Huntington's disease. Electroencephalogr. Clin. Neurophysiol., 1992, 85(3), 197-208.
86. Modugno, N.; Curra, A.; Giovannelli, M.; Priori, A.; Squitieri, F.; Ruggieri, S.; Manfredi, M.; Berardelli, A. The prolonged cortical silent period in patients with Huntington's disease. Clin. Neurophysiol., 2001, 112(8), 1470-4.
87. Schippling, S.; Schneider, S. A.; Bhatia, K. P.; Munchau, A.; Rothwell, J. C.; Tabrizi, S. J.; Orth, M. Abnormal motor cortex excitability in preclinical and very early Huntington's disease. Biol. Psychiatry, 2009, 65(11), 959-65.
88. Nardone, R.; Lochner, P.; Marth, R.; Ausserer, H.; Bratti, A.; Tezzon, F. Abnormal intracortical facilitation in early-stage Huntington's disease. Clin. Neurophysiol., 2007, 118(5), 1149-54.
89. Lorenzano, C.; Dinapoli, L.; Gilio, F.; Suppa, A.; Bagnato, S.; Curra, A.; Inghilleri, M.; Berardelli, A. Motor cortical excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease. Clin. Neurophysiol., 2006, 117(8), 1677-81.
90. Milnerwood, A. J.; Gladding, C. M.; Pouladi, M. A.; Kaufman, A. M.; Hines, R. M.; Boyd, J. D.; Ko, R. W.; Vasuta, O. C.; Graham, R. K.; Hayden, M. R.; Murphy, T. H.; Raymond, L. A. early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron, 2010, 65(2), 178-90.
91. Priori, A.; Polidori, L.; Rona, S.; Manfredi, M.; Berardelli, A. Spinal and cortical inhibition in Huntington's chorea. Mov. Disord., 2000, 15(5), 938-46.
92. Lefaucheur, J. P.; Bachoud-Levi, A. C.; Bourdet, C.; Grandmougin, T.; Hantraye, P.; Cesaro, P.; Degos, J. D.; Peschanski, M.; Lisovoski, F. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease. Mov. Disord., 2002, 17(6), 1294-301.
93. Lefaucheur, J. P.; Menard-Lefaucheur, I.; Maison, P.; Baudic, S.; Cesaro, P.; Peschanski, M.; Bachoud-Levi, A. C. Electrophysiological deterioration over time in patients with Huntington's disease. Mov. Disord., 2006, 21(9), 1350-4.
94. Tegenthoff, M.; Vorgerd, M.; Juskowiak, F.; Roos, V.; Malin, J. P. Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington's disease. Electroencephalogr. Clin. Neurophysiol., 1996, 101(4), 298-303.
95. Abbruzzese, G.; Buccolieri, A.; Marchese, R.; Trompetto, C.; Mandich, P.; Schieppati, M. Intracortical inhibition and facilitation are abnormal in Huntington's disease: a paired magnetic stimulation study. Neurosci. Lett., 1997, 228(2), 87-90.
96. Crupi, D.; Ghilardi, M. F.; Mosiello, C.; Di Rocco, A.; Quartarone, A.; Battaglia, F. Cortical and brainstem LTP-like plasticity in Huntington's disease. Brain Res. Bull., 2008, 75(1), 107-14.
97. Brambilla, P.; Perez, J.; Monchieri, S.; Rossini, P. M.; Bonato, C. Transient improvement of tardive dyskinesia induced with rTMS. Neurology, 2003, 61(8), 1155.
98. Koch, G.; Brusa, L.; Caltagirone, C.; Peppe, A.; Oliveri, M.; Stanzione, P.; Centonze, D. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology, 2005, 65(4), 623-5.
99. Koch, G.; Brusa, L.; Carrillo, F.; Lo Gerfo, E.; Torriero, S.; Oliveri, M.; Mir, P.; Caltagirone, C.; Stanzione, P. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology, 2009, 73(2), 113-9.
100. Centonze, D.; Koch, G.; Versace, V.; Mori, F.; Rossi, S.; Brusa, L.; Grossi, K.; Torelli, F.; Prosperetti, C.; Cervellino, A.; Marfia, G. A.; Stanzione, P.; Marciani, M. G.; Boffa, L.; Bernardi, G. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology, 2007, 68(13), 1045-50.
101. Calabrese, V.; Guagliano, E.; Sapienza, M.; Mancuso, C.; Butterfield, D. A.; Stella, A. M. Redox regulation of cellular stress response in neurodegenerative disorders. Ital. J. Biochem., 2006, 55(3-4), 263-82.
102. Post, A.; Muller, M. B.; Engelmann, M.; Keck, M. E. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur. J. Neurosci., 1999, 11(9), 3247-54.
103. Arendash, G. W.; Sanchez-Ramos, J.; Mori, T.; Mamcarz, M.; Lin, X.; Runfeldt, M.; Wang, L.; Zhang, G.; Sava, V.; Tan, J.; Cao, C. Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice. J. Alzheimers Dis., 2010, 19(1), 191-210.
104. Ihara, Y.; Takata, H.; Tanabe, Y.; Nobukuni, K.; Hayabara, T. Influence of repetitive transcranial magnetic stimulation on disease severity and oxidative stress markers in the cerebrospinal fluid of patients with spinocerebellar degeneration. Neurol. Res., 2005, 27(3), 310-3.
105. Peretto, P.; Merighi, A.; Fasolo, A.; Bonfanti, L. The subependymal layer in rodents: a site of structural plasticity and cell migration in the adult mammalian brain. Brain Res. Bull., 1999, 49(4), 221-43.
106. Alvarez-Buylla, A.; Lim, D. A. For the long run: maintaining germinal niches in the adult brain. Neuron, 2004, 41(5), 683-6.
107. Arias-Carrion, O.; Drucker-Colin, R. Neurogenesis as a therapeutic strategy to regenerate central nervous system. Rev. Neurol., 2007, 45(12), 739-45.
108. Arias-Carrion, O.; Olivares-Bunuelos, T.; Drucker-Colin, R. Neurogenesis in the adult brain. Rev. Neurol., 2007, 44(9), 541-50.
109. Arvidsson, A.; Collin, T.; Kirik, D.; Kokaia, Z.; Lindvall, O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med., 2002, 8(9), 963-70.
110. Jin, K.; Minami, M.; Lan, J. Q.; Mao, X. O.; Batteur, S.; Simon, R. P.; Greenberg, D. A. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. U.S.A., 2001, 98(8), 4710-5.
111. Yamashita, T.; Ninomiya, M.; Hernandez Acosta, P.; Garcia-Verdugo, J. M.; Sunabori, T.; Sakaguchi, M.; Adachi, K.; Kojima, T.; Hirota, Y.; Kawase, T.; Araki, N.; Abe, K.; Okano, H.; Sawamoto, K. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J. Neurosci., 2006, 26(24), 6627-36.
112. Parent, J. M.; Vexler, Z. S.; Gong, C.; Derugin, N.; Ferriero, D. M. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol., 2002, 52(6), 802-13.
113. Shen, C. C.; Yang, Y. C.; Chiao, M. T.; Cheng, W. Y.; Ko, J. L.; Tsuei, Y. S. Characterization of endogenous neural progenitor cells after experimental ischemic stroke. Curr. Neurovasc. Res., 2010, 7(1), 6-14.
114. Craig, C. G.; Tropepe, V.; Morshead, C. M.; Reynolds, B. A.; Weiss, S.; van der Kooy, D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J. Neurosci., 1996, 16(8), 2649-58.
115. Fallon, J.; Reid, S.; Kinyamu, R.; Opole, I.; Opole, R.; Baratta, J.; Korc, M.; Endo, T. L.; Duong, A.; Nguyen, G.; Karkehabadhi, M.; Twardzik, D.; Patel, S.; Loughlin, S. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc. Natl. Acad. Sci. U.S.A., 2000, 97(26), 14686-91.
116. Kuhn, H. G.; Winkler, J.; Kempermann, G.; Thal, L. J.; Gage, F. H. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J. Neurosci., 1997, 17(15), 5820-9.
117. Zigova, T.; Pencea, V.; Wiegand, S. J.; Luskin, M. B. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol. Cell Neurosci., 1998, 11(4), 234-45.
118. Shingo, T.; Sorokan, S. T.; Shimazaki, T.; Weiss, S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci., 2001, 21(24), 9733-43.
119. Curtis, M. A.; Penney, E. B.; Pearson, A. G.; van Roon-Mom, W. M.; Butterworth, N. J.; Dragunow, M.; Connor, B.; Faull, R. L. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc. Natl. Acad. Sci. U.S.A., 2003, 100(15), 9023-7.
120. Curtis, M. A.; Penney, E. B.; Pearson, J.; Dragunow, M.; Connor, B.; Faull, R. L. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience, 2005, 132(3), 777-88.
121. Snyder, B. R.; Chiu, A. M.; Prockop, D. J.; Chan, A. W. Human multipotent stromal cells(MSCs) Increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for huntington's disease. PLoS One, 2010, 5(2), e9347.
122. Arias-Carrion, O.; Hernandez-Lopez, S.; Ibanez-Sandoval, O.; Bargas, J.; Hernandez-Cruz, A.; Drucker-Colin, R. Neuronal precursors within the adult rat subventricular zone differentiate into dopaminergic neurons after substantia nigra lesion and chromaffin cell transplant. J. Neurosci. Res., 2006, 84(7), 1425-37.
123. Arias-Carrion, O.; Verdugo-Diaz, L.; Feria-Velasco, A.; Millan-Aldaco, D.; Gutierrez, A. A.; Hernandez-Cruz, A.; Drucker-Colin, R. Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions. J. Neurosci. Res., 2004, 78(1), 16-28.
124. Bai, J.; Nakamura, H.; Kwon, Y. W.; Hattori, I.; Yamaguchi, Y.; Kim, Y. C.; Kondo, N.; Oka, S.; Ueda, S.; Masutani, H.; Yodoi, J. Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J. Neurosci., 2003, 23(2), 503-9.
125. Zhao, F.; Wu, T.; Lau, A.; Jiang, T.; Huang, Z.; Wang, X. J.; Chen, W.; Wong, P. K.; Zhang, D. D. Nrf2 promotes neuronal cell differentiation. Free Radic. Biol. Med., 2009, 47(6), 867-79.
126. Kosaka, K.; Mimura, J.; Itoh, K.; Satoh, T.; Shimojo, Y.; Kitajima, C.; Maruyama, A.; Yamamoto, M.; Shirasawa, T. Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. J. Biochem., 2010, 147(1), 73-81.